Bone-building drug that prevents fractures in people with osteoporosis approved for use in UK
on
Medical News
Bone-building drug that prevents fractures in people with osteoporosis approved for use in UK
A new anti-osteoporosis drug has just been approved for use in the UK. The drug, called abaloparatide, is licensed for post-menopausal women with osteoporosis and a very high risk of fractures. Abaloparatide’s approval could benefit more than 14,000 women in the UK who are at serious risk of bone fracture.
